Nanostructured Lipid Carriers based mRNA vaccine leads to a T cell–inflamed tumor microenvironment favorable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumor model

ABSTRACT: Using RNA-seq analysis, we have described the impact of a mRNA based vaccine on intratumoral immune-related transcriptional signature in a B16-OVA cold model

ORGANISM(S): Mus musculus

PROVIDER: GSE282402 | GEO | 2025/02/05

REPOSITORIES: GEO